Score | 28 |
|---|---|
Vol 24 h | 608,35 $ |
Liquidité | 2,1 k $ |
Supports | 95 |
Audits | |
L'âge | 2 jours |
FDV | 2 k $ |
Cap boursière | 2 k $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Mise à jour des informations sur le jetonStatistiques Cours mRNA/SOL
Le cours actuel de mRNA (mRNA/SOL) sur PumpSwap est de 0,00000201 $, le cours a augmenté de 2,99 % au cours des dernières 24 heures. Le volume d'échange sur 24 heures serait de 608,35 $ avec un total de 15 transactions. L'adresse du contrat mRNA/SOL est 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, avec une valorisation entièrement diluée (FDV) de 2 010,19 $ et une pool de liquidités de 2 100,38 $.
